• Aucun résultat trouvé

LV, Meng, et al. & the COVID-19 evidence and recommendations working group

N/A
N/A
Protected

Academic year: 2022

Partager "LV, Meng, et al. & the COVID-19 evidence and recommendations working group"

Copied!
2
0
0

Texte intégral

(1)

Article

Reference

Coronavirus disease (COVID-19): a scoping review

LV, Meng, et al. & the COVID-19 evidence and recommendations working group

Abstract

BackgroundIn December 2019, a pneumonia caused by a novel coronavirus (SARS-CoV-2) emerged in Wuhan, China and has rapidly spread around the world since then.AimThis study aims to understand the research gaps related to COVID-19 and propose recommendations for future research.MethodsWe undertook a scoping review of COVID-19, comprehensively searching databases and other sources to identify literature on COVID-19 between 1 December 2019 and 6 February 2020. We analysed the sources, publication date, type and topic of the retrieved articles/studies.ResultsWe included 249 articles in this scoping review.

More than half (59.0%) were conducted in China. Guidance/guidelines and consensuses statements (n = 56; 22.5%) were the most common. Most (n = 192; 77.1%) articles were published in peer-reviewed journals, 35 (14.1%) on preprint servers and 22 (8.8%) posted online. Ten genetic studies (4.0%) focused on the origin of SARS-CoV-2 while the topics of molecular studies varied. Nine of 22 epidemiological studies focused on estimating the basic reproduction number of COVID-19 infection (R0). Of all identified [...]

LV, Meng, et al . & the COVID-19 evidence and recommendations working group. Coronavirus disease (COVID-19): a scoping review. Euro Surveillance , 2020, vol. 25, no. 15, p. 2000125

DOI : 10.2807/1560-7917.ES.2020.25.15.2000125 PMID : 32317050

Available at:

http://archive-ouverte.unige.ch/unige:151709

Disclaimer: layout of this document may differ from the published version.

1 / 1

(2)

Supplementary Table S1 Infectious diseases journals searched

"This supplementary material is hosted by Eurosurveillance as supporting information alongside the article [Coronavirus disease (COVID-19): a scoping review], on behalf of the authors, who remain responsible for the accuracy and appropriateness of the content. The same standards for ethics, copyright, attributions and permissions as for the article apply. Supplements are not edited by Eurosurveillance and the journal is not responsible for the maintenance of any links or email addresses provided therein."

No. Journal URL

1 LANCET INFECTIOUS DISEASES https://www.thelancet.com/journals/laninf/home 2 CLINICAL INFECTIOUS DISEASES https://academic.oup.com/cid

3 EUROSURVEILLANCE https://www.eurosurveillance.org/

4 EMERGING INFECTIOUS DISEASES

https://wwwnc.cdc.gov/eid/

5 CLINICAL MICROBIOLOGY AND INFECTION

https://www.clinicalmicrobiologyandinfection.com/

6 JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

https://academic.oup.com/jac

7 JOURNAL OF INFECTION https://www.journalofinfection.com/

8 JOURNAL OF INFECTIOUS DISEASES

https://academic.oup.com/jid

9 ACS INFECTIOUS DISEASES https://pubs.acs.org/journal/aidcbc 10 TRAVEL MEDICINE AND

INFECTIOUS DISEASE

https://www.sciencedirect.com/journal/travel- medicine-and-infectious-disease

11 VIRULENCE https://www.tandfonline.com/toc/kvir20/current 12 INFECTIOUS DISEASE CLINICS OF

NORTH AMERICA

https://www.sciencedirect.com/journal/infectious- disease-clinics-of-north-america

Références

Documents relatifs

Cette nouvelle souche SARS-CoV-2 ou COVID19 identifiée pour la première fois en chine dans la ville de Wuhan de la province de Hubei à la fin de l’année 2019, la propagation

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.. JAMA Intern

Comme pour l’infarctus du myocarde, les données quant à la relation entre la maladie (Covid-19) liée au coronavirus type 2 (SARS-CoV-2) et l’AVC sont contradictoires : tandis

Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. Characterization and clinical

Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an ongoing pandemic that profoundly challenges healthcare systems

Abstract: The outbreak of Coronavirus Disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has significantly affected the dental

Huang C, Wang Y, Li X, et al.— Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.. Chan JF-W, Yuan S, Kok K-H, et al.— A familial cluster of

La pandémie actuelle à coronavirus (COVID-19, coronavirus disease-19) est causée par le virus SARS-CoV-2 (Severe Acute Respiratory Syndrome CoronaVirus 2) qui a